Scribe Therapeutics Inc. SCTX
16.70 USD +1.00 (+6.37%)
Nov 9, 2026, 3:23 PM EST
15.69 Day range 17.40
13.50 52-week range 39.60
- YTD
- -11.97%
- 1 year
- -11.97%
- Market cap
- 316.16M
- EPS (ttm)
- -3.84
- YTD return
- -11.97%
- 1-year return
- -11.97%
- Volume
- 244.35K
- Avg volume
- 383.51K
- Open
- 15.99
- Previous close
- 15.70
- Day's range
- 15.69 – 17.40
- 52-week range
- 13.50 – 39.60
5D +0.55 (+3.63%)
Financials — quick view
SCTX Revenue — quarterly 1.92M
SCTX Net income — quarterly -6.48M
SCTX EPS — quarterly -2.62
News
Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences 
Scribe Therapeutics To Present Data In American Heart Association’s Scientific Sessions On Its Three Clinical Programs 
Scribe Therapeutics to Present Updated Data on PCSK9-Targeting Epigenetic Silencing and LPA-Targeting Gene Editing Programs at American Heart Association (AHA) Scientific Sessions 2026 
Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday 
Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up 
12 Health Care Stocks Moving In Wednesday's Intraday Session 
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets 
12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
HC Wainwright & Co. Reiterates Buy on Scribe Therapeutics, Maintains $60 Price Target - Scribe Therapeutics Q3 EPS $(2.62) Misses $(1.05) Estimate, Sales $1.918M Miss $3.113M Estimate
Your note
Sign in to keep a note on SCTX — it syncs with the Stock Master app.